Immunophenotyping of male breast cancer

Robert Kornegoor, Anoek H J Verschuur-Maes, Horst Buerger, Marieke C. Hogenes, Peter C. De Bruin, Joost J. Oudejans, Bernd Hinrichs, Paul J. Van Diest

Research output: Contribution to journalArticle

Abstract

Aims: Male breast cancer is a rare disease, and knowledge of carcinogenesis is limited. Conflicting results, based on small series, have been reported for clinically relevant biomarkers. Methods and results: One hundred and thirty-four cases of male breast cancer were immunohistochemically stained on tissue microarrays for oestrogen receptor (ER), progesterone receptor (PR), androgen receptor, human epidermal growth factor receptor 2 (HER2), BRST2, cyclinD1, bcl-2, p53, p16, p21, Ki67, cytokeratin (CK) 5/6, CK14, and epidermal growth factor receptor. Data were correlated with clinicopathological features and patient outcome. High mitotic count and high grade were correlated with high Ki67, HER2 amplification/overexpression, p53 accumulation, high p21 expression, low PR expression, and low bcl-2 expression. PR negativity (P=0.009) and p53 accumulation (P=0.042) were correlated with decreased 5-year survival and were independent markers for patient outcome in Cox regression. In unsupervised hierarchical clustering, four groups were identified that were correlated with distinctive clinicopathological features. The hormone negative/ER-positive/high-grade cluster was significantly associated with decreased survival (P=0.011) and was an independent prognostic factor in Cox regression. Conclusions: Several tissue biomarkers are associated with an aggressive phenotype in male breast cancer. PR and p53 are the most promising individual prognostic markers. On the basis of immunophenotype, four distinctive and prognostically relevant male breast cancer groups were identified, indicating that protein expression profiling may be clinically useful in male breast cancer.

Original languageEnglish (US)
Pages (from-to)1145-1155
Number of pages11
JournalHistopathology
Volume61
Issue number6
DOIs
Publication statusPublished - Dec 2012
Externally publishedYes

    Fingerprint

Keywords

  • Breast cancer
  • Immunohistochemistry
  • Male
  • Prognosis
  • Unsupervised hierarchical clustering

ASJC Scopus subject areas

  • Histology
  • Pathology and Forensic Medicine

Cite this

Kornegoor, R., Verschuur-Maes, A. H. J., Buerger, H., Hogenes, M. C., De Bruin, P. C., Oudejans, J. J., ... Van Diest, P. J. (2012). Immunophenotyping of male breast cancer. Histopathology, 61(6), 1145-1155. https://doi.org/10.1111/j.1365-2559.2012.04330.x